Medicaid pulled a 19-year-old cancer survivor's coverage 5 years into remission

For healthcare leaders and clinicians, Taya Hailstone's case is a stark warning about what happens when Medicaid eligibility decisions are decoupled from clinical evidence. Montana discontinued her disability coverage without requesting records from the oncology and specialist teams managing her post-remission organ and nerve damage — a procedural gap with direct consequences for care continuity, medication access, and avoidable hospitalizations. As new federal work requirements push states to review medical exemptions across a much larger swath of enrollees, the risk of clinically uninformed disenrollment is scaling up.

Taya Hailstone, a 19-year-old Montana woman who has been in remission from childhood Hodgkin lymphoma for five years, lost her Medicaid disability coverage last year — not because her condition improved, but because she stopped receiving Social Security disability payments in the hope of getting healthy enough to work. Montana's health department used the cessation of those payments as the trigger to rule her ineligible for disability Medicaid and switched her to the state's Children's Health Insurance Program three months before she aged out at 19. Critically, according to letters from her doctors reviewed by KFF Health News, the state never sought records from the medical team treating her before making the ruling.

“

For healthcare leaders and clinicians, Taya Hailstone's case is a stark warning about what happens when Medicaid eligibility decisions are decoupled from clinical evidence.

The case is a precise illustration of the "benefits cliff" that has long plagued disability coverage. Medicaid disability eligibility is frequently tethered to receipt of Supplemental Security Income or Social Security disability benefits, which carry strict income and asset limits. A beneficiary who attempts to work — or even signals that intent — risks losing both the cash benefit and the health coverage attached to it. Hailstone said she stopped the payments because she wanted to save money beyond what the caps allow, yet her organ and nerve damage still makes basic tasks like loading a dishwasher difficult and leaves her too sick to work consistently. The result is a perverse incentive: the system penalizes the very recovery it ostensibly encourages.

The administrative failure is equally significant. Montana reached its determination without pulling clinical records from Hailstone's treating team, meaning an eligibility decision with life-altering consequences for someone managing the long-term effects of cancer was made in a clinical vacuum. That disconnect between administrative eligibility and clinical reality is the core health-system problem here. For patients with fluctuating, chronic, post-treatment conditions, a single point-in-time administrative review can be medically arbitrary.

This is now scaling into a broader national issue. New federal Medicaid work requirements are pushing states to adjudicate medical exemptions for a much larger swath of enrollees, not just those already flagged for disability review. Conservatives who championed work requirements often promised that vulnerable people would get a pass, but the exemption process itself demands exactly the kind of case-by-case medical review that failed Hailstone. Each additional review is another opportunity for the procedural disenrollment that already surged during the unwinding of pandemic-era continuous coverage protections, when millions of Americans lost Medicaid for paperwork reasons rather than true ineligibility.

For the healthcare system, the stakes are direct and measurable. Losing Medicaid means losing access to the specialists, medications, and monitoring that keep a cancer survivor stable. Hailstone herself said she cannot afford the treatment to manage the aftermath of her cancer without it, and she has been able to keep coverage only because her appeal is pending. Coverage interruptions for complex patients correlate with delayed care, avoidable emergency use, and worse long-term outcomes — costs that ultimately shift onto hospitals, providers, and state budgets.